Filed: 8/13/2026ACC: 0002050194-26-000005
📋 What this filing means
SPRUCE STREET CAPITAL LP filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $509.68M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$509.68M
Total AUM (reported)
48.38M
Total Shares
Allocation by class
COM$275.47M54.0%
COM SHS$80.37M15.8%
ORD SHS CL A$64.06M12.6%
COM NEW$48.84M9.6%
SHS$28.50M5.6%
USD CL A ORD SHS$5.32M1.0%
ADR$5.30M1.0%
Portfolio Concentration
Top 3$159.21M31.2%
4–10$198.77M39.0%
11–25$134.26M26.3%
Rest$17.44M3.4%
Top 3 weight
31.2%
Top 10 weight
70.2%
Voting Authority Distribution
Total shares with voting rights: 48.38M
Sole
Full voting authority
48.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
KINIKSA PHARMACEUTICALS INTL
SOLEShares918.07K
TypeSH
Market value$58.71M
11.52%
Sole
918.07K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares2.98M
TypeSH
Market value$55.83M
10.95%
Sole
2.98M
Shared
0.00
None
0.00
LB PHARMACEUTICALS INC
SOLEShares1.38M
TypeSH
Market value$44.66M
8.76%
Sole
1.38M
Shared
0.00
None
0.00
RELMADA THERAPEUTICS INC
SOLEShares6.39M
TypeSH
Market value$44.23M
8.68%
Sole
6.39M
Shared
0.00
None
0.00
ALTO NEUROSCIENCE INC
SOLEShares1.35M
TypeSH
Market value$35.71M
7.01%
Sole
1.35M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares354.82K
TypeSH
Market value$34.59M
6.79%
Sole
354.82K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares543.88K
TypeSH
Market value$28.50M
5.59%
Sole
543.88K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares3.45M
TypeSH
Market value$21.27M
4.17%
Sole
3.45M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares306.05K
TypeSH
Market value$17.79M
3.49%
Sole
306.05K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares329.01K
TypeSH
Market value$16.70M
3.28%
Sole
329.01K
Shared
0.00
None
0.00
ENANTA PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$15.87M
3.11%
Sole
1.09M
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares3.69M
TypeSH
Market value$12.60M
2.47%
Sole
3.69M
Shared
0.00
None
0.00
INFLARX NV
SOLEShares5.35M
TypeSH
Market value$11.99M
2.35%
Sole
5.35M
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares432.04K
TypeSH
Market value$11.21M
2.20%
Sole
432.04K
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares392.57K
TypeSH
Market value$11.05M
2.17%
Sole
392.57K
Shared
0.00
None
0.00
CENTURY THERAPEUTICS INC
SOLEShares4.06M
TypeSH
Market value$9.94M
1.95%
Sole
4.06M
Shared
0.00
None
0.00
MINERVA NEUROSCIENCES INC
SOLEShares1.66M
TypeSH
Market value$9.19M
1.80%
Sole
1.66M
Shared
0.00
None
0.00
SAB BIOTHERAPEUTICS INC
SOLEShares2.20M
TypeSH
Market value$8.57M
1.68%
Sole
2.20M
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares1.66M
TypeSH
Market value$8.04M
1.58%
Sole
1.66M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares422.54K
TypeSH
Market value$7.74M
1.52%
Sole
422.54K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares3.58M
TypeSH
Market value$7.27M
1.43%
Sole
3.58M
Shared
0.00
None
0.00
RESEARCH ALLIANCE CORP III
SOLEShares500K
TypeSH
Market value$5.35M
1.05%
Sole
500K
Shared
0.00
None
0.00
HELIX ACQUISITION CORP III
SOLEShares500K
TypeSH
Market value$5.32M
1.04%
Sole
500K
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares279.11K
TypeSH
Market value$5.30M
1.04%
Sole
279.11K
Shared
0.00
None
0.00
ACHIEVE LIFE SCIENCE INC
SOLEShares736.64K
TypeSH
Market value$4.81M
0.94%
Sole
736.64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KINIKSA PHARMACEUTICALS INTLSOLE | ORD SHS CL A | 918.07K | SH | $58.71M 11.52% | 918.07K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 2.98M | SH | $55.83M 10.95% | 2.98M | 0.00 | 0.00 |
LB PHARMACEUTICALS INCSOLE | COM SHS | 1.38M | SH | $44.66M 8.76% | 1.38M | 0.00 | 0.00 |
RELMADA THERAPEUTICS INCSOLE | COM | 6.39M | SH | $44.23M 8.68% | 6.39M | 0.00 | 0.00 |
ALTO NEUROSCIENCE INCSOLE | COM SHS | 1.35M | SH | $35.71M 7.01% | 1.35M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 354.82K | SH | $34.59M 6.79% | 354.82K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 543.88K | SH | $28.50M 5.59% | 543.88K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.45M | SH | $21.27M 4.17% | 3.45M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 306.05K | SH | $17.79M 3.49% | 306.05K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 329.01K | SH | $16.70M 3.28% | 329.01K | 0.00 | 0.00 |
ENANTA PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $15.87M 3.11% | 1.09M | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 3.69M | SH | $12.60M 2.47% | 3.69M | 0.00 | 0.00 |
INFLARX NVSOLE | COM | 5.35M | SH | $11.99M 2.35% | 5.35M | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 432.04K | SH | $11.21M 2.20% | 432.04K | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 392.57K | SH | $11.05M 2.17% | 392.57K | 0.00 | 0.00 |
CENTURY THERAPEUTICS INCSOLE | COM | 4.06M | SH | $9.94M 1.95% | 4.06M | 0.00 | 0.00 |
MINERVA NEUROSCIENCES INCSOLE | COM NEW | 1.66M | SH | $9.19M 1.80% | 1.66M | 0.00 | 0.00 |
SAB BIOTHERAPEUTICS INCSOLE | COM NEW | 2.20M | SH | $8.57M 1.68% | 2.20M | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 1.66M | SH | $8.04M 1.58% | 1.66M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 422.54K | SH | $7.74M 1.52% | 422.54K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 3.58M | SH | $7.27M 1.43% | 3.58M | 0.00 | 0.00 |
RESEARCH ALLIANCE CORP IIISOLE | ORD SHS CL A | 500K | SH | $5.35M 1.05% | 500K | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIISOLE | USD CL A ORD SHS | 500K | SH | $5.32M 1.04% | 500K | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 279.11K | SH | $5.30M 1.04% | 279.11K | 0.00 | 0.00 |
ACHIEVE LIFE SCIENCE INCSOLE | COM | 736.64K | SH | $4.81M 0.94% | 736.64K | 0.00 | 0.00 |
Page 1 of 2